← Back to Search

Behavioral Intervention

Arm I- Usual care for Chronic Lymphocytic Leukemia

N/A
Waitlist Available
Led By Lauren Hamel, PhD
Research Sponsored by Barbara Ann Karmanos Cancer Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months after the patient-physician interaction
Awards & highlights

Study Summary

This trial studies how well an app called DISCO (DIScussion of COst) works in improving financial outcomes for patients with hematologic cancer. The app is an electronic, highly scalable and tailorable education and communication intervention that may help researchers learn more about improving how patients and oncologists discuss cancer treatment costs.

Eligible Conditions
  • Chronic Lymphocytic Leukemia
  • Chronic Myelogenous Leukemia
  • Multiple Myeloma

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months after the patient-physician interaction
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months after the patient-physician interaction for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Presence of cost discussion observed via video recordings of patient-physician treatment discussions.
Secondary outcome measures
Anticipated material hardship
Financial toxicity
Referrals for financial or psychological support
+3 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: Arm II - DISCO appExperimental Treatment1 Intervention
Patients use the DISCO education and communication app before attending video-recorded meetings with their oncologist to discuss treatment plans.
Group II: Arm I- Usual careExperimental Treatment1 Intervention
Patients receive usual care consisting of general cancer treatment information on a sheet of paper before attending video-recorded meetings with their oncologist to discuss treatment plans.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
The DISCO App
2020
N/A
~30
Usual Care
1990
Completed Phase 4
~7710

Find a Location

Who is running the clinical trial?

Barbara Ann Karmanos Cancer InstituteLead Sponsor
163 Previous Clinical Trials
9,244 Total Patients Enrolled
Lauren Hamel, PhDPrincipal Investigator - Barbara Ann Karmanos Institute
Barbara Ann Karmanos Cancer Institute
1 Previous Clinical Trials
260 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the peak capacity of individuals partaking in this clinical trial?

"Affirmative. Data on clinicaltrials.gov states that this research project, initially posted on February 25th 2020, is now actively enrolling individuals. 68 patients are need to be recruited from 1 location."

Answered by AI

Is this experiment actively seeking participants?

"Affirmative. According to records on clinicaltrials.gov, this medical experiment is presently in search of individuals that meet their criteria. Initially posted on February 25th 2020, the trial was recently edited on May 31st 2022 and they are aiming to recruit 68 patients from a single location."

Answered by AI
~5 spots leftby Mar 2025